Medi Caps Ltd
Incorporated in 1983, Medi-Caps Limited flagship company of Medi-Caps Group, is one of the largest manufacturer of empty hard gelatin capsules in terms of manufacturing capacity as well as market capitalization in India. The company together with its subsidiary & now as real estate manages the marketing, production and distribution of products. [1]
- Market Cap ₹ 62.2 Cr.
- Current Price ₹ 49.9
- High / Low ₹ 63.5 / 36.1
- Stock P/E
- Book Value ₹ 97.0
- Dividend Yield 0.00 %
- ROCE -1.04 %
- ROE -1.87 %
- Face Value ₹ 10.0
Pros
- Company is almost debt free.
- Stock is trading at 0.51 times its book value
Cons
- Company has low interest coverage ratio.
- The company has delivered a poor sales growth of -12.0% over past five years.
- Company has a low return on equity of 2.47% over last 3 years.
- Debtor days have increased from 86.5 to 144 days.
- Working capital days have increased from 341 days to 727 days
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Sector: Realty Industry: Construction
Quarterly Results
Consolidated Figures in Rs. Crores / View Standalone
Profit & Loss
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 30.02 | 37.49 | 36.11 | 42.97 | 44.04 | 53.70 | 51.79 | 43.05 | 58.72 | 69.87 | 49.37 | 27.34 | |
| 26.39 | 33.78 | 36.19 | 40.36 | 42.43 | 51.53 | 47.07 | 49.80 | 46.44 | 59.80 | 44.18 | 27.38 | |
| Operating Profit | 3.63 | 3.71 | -0.08 | 2.61 | 1.61 | 2.17 | 4.72 | -6.75 | 12.28 | 10.07 | 5.19 | -0.04 |
| OPM % | 12.09% | 9.90% | -0.22% | 6.07% | 3.66% | 4.04% | 9.11% | -15.68% | 20.91% | 14.41% | 10.51% | -0.15% |
| -1.26 | -1.18 | 1.29 | 0.68 | 2.02 | 1.07 | 2.73 | 2.86 | 0.46 | 1.95 | 1.49 | 0.48 | |
| Interest | 0.51 | 1.16 | 0.66 | 0.06 | 0.10 | 0.10 | 0.13 | 0.12 | 0.10 | 0.11 | 0.13 | -0.00 |
| Depreciation | 2.12 | 2.07 | 1.81 | 1.80 | 1.81 | 1.79 | 1.82 | 1.83 | 1.52 | 1.81 | 1.74 | 1.69 |
| Profit before tax | -0.26 | -0.70 | -1.26 | 1.43 | 1.72 | 1.35 | 5.50 | -5.84 | 11.12 | 10.10 | 4.81 | -1.25 |
| Tax % | 442.31% | 155.71% | 63.49% | 39.16% | 20.35% | 14.81% | 2.18% | 0.17% | -0.09% | 0.10% | 63.62% | 80.00% |
| -1.41 | -1.79 | -2.06 | 0.86 | 1.37 | 1.15 | 5.39 | -5.85 | 11.13 | 10.08 | 1.76 | -2.24 | |
| EPS in Rs | -0.57 | -1.04 | -1.65 | 0.69 | 1.10 | 0.92 | 4.32 | -4.69 | 8.93 | 8.08 | 1.41 | -1.80 |
| Dividend Payout % | -0.00% | -0.00% | -0.00% | -0.00% | -0.00% | -0.00% | -0.00% | -0.00% | -0.00% | -0.00% | -0.00% | -0.00% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | -3% |
| 5 Years: | -12% |
| 3 Years: | -22% |
| TTM: | -45% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | -11% |
| 5 Years: | % |
| 3 Years: | % |
| TTM: | -282% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 15% |
| 5 Years: | 23% |
| 3 Years: | 2% |
| 1 Year: | 31% |
| Return on Equity | |
|---|---|
| 10 Years: | 2% |
| 5 Years: | 3% |
| 3 Years: | 2% |
| Last Year: | -2% |
Balance Sheet
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 12.47 | 12.47 | 12.47 | 12.47 | 12.47 | 12.47 | 12.47 | 12.47 | 12.47 | 12.47 | 12.47 | 12.47 |
| Reserves | 75.47 | 71.00 | 68.94 | 69.80 | 76.62 | 77.75 | 83.13 | 78.48 | 92.24 | 103.79 | 106.10 | 108.51 |
| 6.27 | 8.87 | 0.81 | 0.08 | 0.09 | 0.17 | 0.12 | 0.06 | -0.00 | -0.00 | -0.00 | -0.00 | |
| 8.22 | 9.60 | 7.00 | 10.68 | 8.19 | 10.52 | 10.89 | 4.20 | 10.11 | 14.09 | 7.42 | 6.30 | |
| Total Liabilities | 102.43 | 101.94 | 89.22 | 93.03 | 97.37 | 100.91 | 106.61 | 95.21 | 114.82 | 130.35 | 125.99 | 127.28 |
| 38.96 | 36.92 | 58.05 | 56.41 | 62.14 | 61.03 | 59.80 | 57.30 | 58.12 | 59.31 | 58.91 | 57.57 | |
| CWIP | -0.00 | 0.10 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | 0.97 | 0.54 | 0.24 | -0.00 | -0.00 |
| Investments | 28.40 | 33.72 | 5.43 | 6.74 | 7.83 | 11.18 | 16.35 | 21.97 | 29.41 | 30.67 | 32.07 | 39.46 |
| 35.07 | 31.20 | 25.74 | 29.88 | 27.40 | 28.70 | 30.46 | 14.97 | 26.75 | 40.13 | 35.01 | 30.25 | |
| Total Assets | 102.43 | 101.94 | 89.22 | 93.03 | 97.37 | 100.91 | 106.61 | 95.21 | 114.82 | 130.35 | 125.99 | 127.28 |
Cash Flows
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -13.93 | -1.50 | 7.05 | 2.59 | 4.02 | 4.20 | 5.96 | 4.63 | 15.32 | 7.02 | -6.08 | 6.94 | |
| 6.42 | 1.54 | -6.97 | -1.47 | 2.57 | -4.09 | -5.75 | -5.80 | -9.70 | -4.08 | -2.56 | -7.73 | |
| 6.75 | -0.00 | -0.00 | -0.73 | -5.76 | 0.08 | -0.05 | -0.06 | -0.06 | -0.00 | -0.00 | -0.00 | |
| Net Cash Flow | -0.76 | 0.04 | 0.08 | 0.39 | 0.83 | 0.20 | 0.16 | -1.23 | 5.56 | 2.95 | -8.64 | -0.79 |
Ratios
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 103.35 | 111.96 | 87.33 | 82.48 | 74.09 | 88.57 | 90.56 | 37.39 | 39.72 | 52.61 | 62.55 | 144.45 |
| Inventory Days | 309.86 | 235.89 | 265.71 | 257.13 | 230.21 | 148.16 | 163.52 | 75.29 | 93.95 | 156.60 | 121.72 | 220.07 |
| Days Payable | 53.67 | 52.74 | 66.33 | 101.86 | 75.75 | 90.99 | 96.26 | 26.94 | 86.24 | 154.35 | 48.72 | 70.16 |
| Cash Conversion Cycle | 359.55 | 295.12 | 286.71 | 237.75 | 228.56 | 145.73 | 157.82 | 85.74 | 47.42 | 54.85 | 135.55 | 294.36 |
| Working Capital Days | 290.10 | 182.65 | 184.07 | 154.26 | 147.11 | 113.51 | 127.85 | 85.21 | 63.96 | 87.66 | 209.52 | 726.66 |
| ROCE % | 2.39% | 0.44% | -0.69% | 1.81% | 1.48% | 1.56% | 5.77% | -6.58% | 11.59% | 8.78% | 3.70% | -1.04% |
Documents
Announcements
- Disclosures under Reg. 29(1) of SEBI (SAST) Regulations, 2011 10 Jul
-
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
6 Jul - Certificate for compliance of Regulation 74(5) of SEBI (Depositories and Participants ) Regulation 2018 for the quarter ended 30.06.2024.
- Closure of Trading Window 27 Jun
- Intimation To The Holders Of Physical Shares In Terms Of SEBI Circular No. SEBI/HO/MIRSD/MIRSD-Pod-1/P/CIR/2023/37 Dated March 16, 2023 Regarding Mandatory Furnishing Of PAN, KYC Details And Nomination. 14 Jun
- Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate 7 Jun
Annual reports
-
Financial Year 2023
from bse
-
Financial Year 2022
from bse
-
Financial Year 2021
from bse
-
Financial Year 2020
from bse
-
Financial Year 2019
from bse
-
Financial Year 2018
from bse
-
Financial Year 2017
from bse
-
Financial Year 2016
from bse
-
Financial Year 2015
from bse
-
Financial Year 2014
from bse
-
Financial Year 2013
from bse
-
Financial Year 2012
from bse
-
Financial Year 2011
from bse
-
Financial Year 2010
from bse
-
Financial Year 2009
from bse
Products:[1]
The company claims its products to be Sodium Lauryl Sulfate(SLS) free and Preservatives free. There are three main products which the company manufactures -
Empty Hard Gelatin Capsules Shells
The company manufactures these Shells in 6 sizes ranging from 00,0,1el,1,2,3,4 fortified with more than thousand shades.
Halal Gelatin Capsules
The company supplies HALAL GELATIN as there are very less suppliers of genuine Halal quality products.
Liquid Filled Capsules
These manufactured capsules are suitable for pharmaceutical, herbal, nutraceutical, agricultural and especially for cosmetic industry. They can be filled with active substances in form of liquids.